Amount Raised
$1.25 Million
Round Type
Post-IPO Equity
DallasOtherBiotechnologyHealth CareDietary SupplementsNutritionInvestors
Description
On September 30, 2026, MangoRx IP Holdings, LLC, a subsidiary of Mangoceuticals, Inc., entered into Subscription Agreements with two accredited investors. One investor agreed to purchase a 12.5% stake in the company for a total of $1,250,000. The payment will be structured with an initial $500,000 upon agreement, followed by $750,000 at a later date.
Fundz sees it the moment MANGOCEUTICALS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MANGOCEUTICALS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.